Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

ResBiotic

ResBiotic develops probiotic and pharmabiotic therapies to alleviate neutrophilic inflammation associated with dysbiosis.
2018
11-50
Vestavia Hills, Alabama, United States

Investment Funding

Last Funding Stage

Undisclosed

Total Funding Amount

7.14M

Last Funding Amount

1.5M

Last Funding Date

26-02-2025

Lead Investors

Timberline Investments

Revenue

$1M to $10M

People

Founders

Something missing or incorrect on this page? Help us enrich this information